Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.18 EUR
−3.79 M EUR
3.91 M EUR
13.73 M
About BIORETEC OY
Sector
Industry
CEO
Alan Donze
Website
Headquarters
Tampere
Founded
1998
ISIN
FI4000480454
FIGI
BBG011J0CZC1
Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. It specializes in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The company's products include bioabsorbable nails, pins, and screws as well as bioresorbable magnesium implants. Bioretec was founded in 1998 and is headquartered in Tampere, Finland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BRETEC is 2.00 EUR — it has decreased by −2.91% in the past 24 hours. Watch BIORETEC OY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange BIORETEC OY stocks are traded under the ticker BRETEC.
BRETEC stock has fallen by −11.11% compared to the previous week, the month change is a 5.26% rise, over the last year BIORETEC OY has showed a −6.54% decrease.
We've gathered analysts' opinions on BIORETEC OY future price: according to them, BRETEC price has a max estimate of 2.40 EUR and a min estimate of 2.40 EUR. Watch BRETEC chart and read a more detailed BIORETEC OY stock forecast: see what analysts think of BIORETEC OY and suggest that you do with its stocks.
BRETEC reached its all-time high on Mar 30, 2023 with the price of 3.75 EUR, and its all-time low was 1.25 EUR and was reached on Dec 29, 2022. View more price dynamics on BRETEC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BRETEC stock is 5.00% volatile and has beta coefficient of 0.74. Track BIORETEC OY stock price on the chart and check out the list of the most volatile stocks — is BIORETEC OY there?
Today BIORETEC OY has the market capitalization of 46.67 M, it has increased by 6.48% over the last week.
Yes, you can track BIORETEC OY financials in yearly and quarterly reports right on TradingView.
BIORETEC OY is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
BRETEC net income for the last half-year is −1.88 M EUR, while the previous report showed −1.71 M EUR of net income which accounts for −9.94% change. Track more BIORETEC OY financial stats to get the full picture.
No, BRETEC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 37.00 employees. See our rating of the largest employees — is BIORETEC OY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIORETEC OY EBITDA is −3.57 M EUR, and current EBITDA margin is −72.53%. See more stats in BIORETEC OY financial statements.
Like other stocks, BRETEC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIORETEC OY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIORETEC OY technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIORETEC OY stock shows the strong sell signal. See more of BIORETEC OY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.